Kernal Biologics specializes in developing mRNA therapies to treat severe diseases such as cancer. Leveraging expertise from MIT, Harvard, and Big Pharma, Kernal utilizes synthetic biology and RNA design to create innovative immunotherapies. The company's distinctive approach involves programming cells to produce their own drugs, offering a promising new frontier in medical treatment.
Kernal Bio is seeking a Vice President of Chemistry Manufacturing and Controls (VP of CMC) to lead the development of mRNA 2.0 therapeutics. This role focuses on scaling up mRNA LNP manufacturing, optimizing process development, and ensuring compliance with Good Manufacturing Practices (GMP). The ideal candidate will have extensive experience in mRNA manufacturing and lead a team to deliver high-quality products.
Kernal Biologics specializes in developing mRNA therapies to treat severe diseases such as cancer. Leveraging expertise from MIT, Harvard, and Big Pharma, Kernal utilizes synthetic biology and RNA design to create innovative immunotherapies. The company's distinctive approach involves programming cells to produce their own drugs, offering a promising new frontier in medical treatment.
Character Bio